Literature DB >> 26400398

Alternatively Spliced Human TREK-1 Variants Alter TREK-1 Channel Function and Localization.

Chad L Cowles1, Yi-Ying Wu1, Scott D Barnett1, Michael T Lee1, Heather R Burkin1, Iain L O Buxton2.   

Abstract

TREK-1, an outward-rectifying potassium channel activated by stretch, is found in the myometrium of pregnant women. Decreased expression of TREK-1 near term suggests that TREK-1 may contribute to uterine quiescence during gestation. Five alternatively spliced TREK-1 variants were identified in the myometrium of mothers who delivered spontaneously preterm (<37 wk), leading to the hypothesis that these TREK-1 variants could interfere with TREK-1 function or expression. To investigate a potential role for these variants, immunofluorescence, cell surface assays, Western blots, and patch clamp were employed to study TREK-1 and TREK-1 variants expressed in HEK293T cells. The results of this study demonstrate that coexpression of TREK-1 with TREK-1 variants alters TREK-1 expression and suppresses channel function. Each variant affected TREK-1 in a disparate manner. In HEK293T cells coexpressing TREK-1 and each variant, TREK-1 membrane expression was diminished with compartmentalization inside the cell. When expressed alone, individual variants displayed channel properties that were significantly decreased compared to full-length TREK-1. In coexpression studies using patch clamp, basal TREK-1 currents were reduced by ∼64% (4.3 vs. 12.0 pA/pF) on average at 0 mV when coexpressed with each variant. TREK-1 currents that were activated by intracellular acidosis were reduced an average of ∼77% (21.4 vs. 94.5 pA/pF) at 0 mV when cells were transfected with TREK-1 and any one of the splice variants. These data correlate the presence of TREK-1 variants to reduced TREK-1 activity, suggesting a pathological role for TREK-1 variants in preterm labor.
© 2015 by the Society for the Study of Reproduction, Inc.

Entities:  

Keywords:  TREK-1; electrophysiology; human myometrial smooth muscle; labor; myometrium; potassium channels; pregnancy; preterm labor; splice variants; uterus

Mesh:

Substances:

Year:  2015        PMID: 26400398      PMCID: PMC4712007          DOI: 10.1095/biolreprod.115.129791

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  35 in total

1.  Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel.

Authors:  F Maingret; A J Patel; F Lesage; M Lazdunski; E Honoré
Journal:  J Biol Chem       Date:  1999-09-17       Impact factor: 5.157

2.  Functionally diverse complement of large conductance calcium- and voltage-activated potassium channel (BK) alpha-subunits generated from a single site of splicing.

Authors:  Lie Chen; Lijun Tian; Stephen H-F MacDonald; Heather McClafferty; Martin S L Hammond; Jean-Marc Huibant; Peter Ruth; Hans-Guenther Knaus; Michael J Shipston
Journal:  J Biol Chem       Date:  2005-08-04       Impact factor: 5.157

3.  Carboxyl-terminal splicing enhances physical interactions between the cytoplasmic tails of purinergic P2X receptors.

Authors:  Taka-aki Koshimizu; Karla Kretschmannova; Mu-Lan He; Susumu Ueno; Akito Tanoue; Nobuyuki Yanagihara; Stanko S Stojilkovic; Gozoh Tsujimoto
Journal:  Mol Pharmacol       Date:  2006-02-08       Impact factor: 4.436

4.  Expression of stretch-activated potassium channels in human myometrium.

Authors:  Jennifer N Tichenor; Eric T Hansen; Iain L O Buxton
Journal:  Proc West Pharmacol Soc       Date:  2005

5.  A mammalian two pore domain mechano-gated S-like K+ channel.

Authors:  A J Patel; E Honoré; F Maingret; F Lesage; M Fink; F Duprat; M Lazdunski
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

6.  Expression of TASK and TREK, two-pore domain K+ channels, in human myometrium.

Authors:  Xilian Bai; George J Bugg; Susan L Greenwood; Jocelyn D Glazier; Colin P Sibley; Philip N Baker; Michael J Taggart; Gregor K Fyfe
Journal:  Reproduction       Date:  2005-04       Impact factor: 3.906

7.  Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel.

Authors:  O Zhuchenko; J Bailey; P Bonnen; T Ashizawa; D W Stockton; C Amos; W B Dobyns; S H Subramony; H Y Zoghbi; C C Lee
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

8.  TREK-1, a K+ channel involved in polymodal pain perception.

Authors:  Abdelkrim Alloui; Katharina Zimmermann; Julien Mamet; Fabrice Duprat; Jacques Noël; Jean Chemin; Nicolas Guy; Nicolas Blondeau; Nicolas Voilley; Catherine Rubat-Coudert; Marc Borsotto; Georges Romey; Catherine Heurteaux; Peter Reeh; Alain Eschalier; Michel Lazdunski
Journal:  EMBO J       Date:  2006-05-04       Impact factor: 11.598

9.  Human immunodeficiency virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility complex class II presentation.

Authors:  Amjad Hussain; Clement Wesley; Mohammad Khalid; Ashutosh Chaudhry; Shahid Jameel
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

10.  Human heart failure is associated with abnormal C-terminal splicing variants in the cardiac sodium channel.

Authors:  Lijuan L Shang; Arnold E Pfahnl; Shamarendra Sanyal; Zhe Jiao; Jon Allen; Kathrin Banach; John Fahrenbach; Daiana Weiss; W Robert Taylor; A Maziar Zafari; Samuel C Dudley
Journal:  Circ Res       Date:  2007-09-27       Impact factor: 17.367

View more
  2 in total

1.  P2Y receptor regulation of K2P channels that facilitate K+ secretion by human mammary epithelial cells.

Authors:  Yotesawee Srisomboon; Nathan A Zaidman; Peter J Maniak; Chatsri Deachapunya; Scott M O'Grady
Journal:  Am J Physiol Cell Physiol       Date:  2018-01-24       Impact factor: 4.249

2.  Arachidonic acid hyperpolarizes mesenchymal stromal cells from the human adipose tissue by stimulating TREK1 K+ channels.

Authors:  Michail V Tarasov; Polina D Kotova; Marina F Bystrova; Natalia V Kabanova; Veronika Yu Sysoeva; Stanislav S Kolesnikov
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.